TREATMENT OF CHOLESTATIC PRURITUS IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (PBC): BASELINE DATA FROM THE PHASE 2B GLIMMER TRIAL

Helen Smith  ¹     Sugato Das  ²     Alexander Currie  ³     Andrea Ribiero  ⁴     andrew walker  ⁴     Megan M. McLaughlin  ^5    
1 GSK, London, United Kingdom
² GSK, Hyderabad, India
³ GSK, Uxbridge, United Kingdom
⁴ GSK, Madrid, Spain
⁵ GSK, Collegeville, United States

Topic
Hepatobiliary

Session
PP 07 Liver & biliary (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)